About Us
Company Profile
Milestones
Corporate Governance
Board of Directors
NEWS ROOM
Infrastructure
R & D
MANUFACTURING
CORPORATE
Contract R&D
PRODUCT DEVELOPMENT
STAND ALONE SERVICES
Regulatory Affairs
Intellectual Property
TECHNOLOGY TRANSFER
Contract Manufacturing
Contract Manufacturing
SCALE UP & REGISTRATION BATCHES
CLINICAL TRIAL SUPPLY
Drug Delivery Technologies
RUBIODT ®
RUBIDT ®
RUBIRETEN ®
RUBIERT ®
RUBIEN ®
RUBISRT ®
RUBICOAT ®
Licensing
DOSSIERS and PRODUCTS
CLIENTELE
CONTACT US
Careers
LIFE AT RUBICON
JOIN THE TEAM
Current Openings
990
330
100
50
false
true
false
true
News and Updates
Rubicon’s GMP plant gets approved by US FDA for Tablet Manufacturing
Rubicon ranks #7 in India for the number of patents filed in the Pharmaceutical Industry
Rubicon GMP plant receives UK MHRA approval
Rubicon develops its 250th project in 2013
Dextromethorphan SR Suspension available for EU and PanAsia Licensing
Rizatriptan ODT (Maxalt MLT) available for licensing in EU and RoW
Ibuprofen Fastmelt Pixie Sticks in various flavours developed
